全球电泳试剂市场规模（按产品、应用、地区、范围和预测）

电泳试剂市场规模及预测

2021 年电泳试剂市场规模价值 12.1 亿美元，预计到 2030 年将达到 25.3 亿美元，2022 年至 2030 年的复合年增长率为 6.99%。推动全球电泳试剂市场大幅成长的主要因素是遗传疾病、技术进步、传染病和癌症的增加，以及多个地区政府对基因组学和蛋白​​质组学研究的高投入。推动全球电泳试剂市场发展的其他因素包括医疗保健基础设施的改善、劳动成本的降低和人均收入的增加。全球电泳试剂市场报告对市场进行了全面的评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

全球电泳试剂市场的定义

电泳是一种利用电荷根据 RNA、DNA 和蛋白质的片段或摩尔质量分离它们的方法。电泳技术中所使用的试剂称为电泳试剂。医学研究、临床应用和生物科学都是使用该技术的行业的例子。利用电泳试剂可以诊断病毒感染和遗传疾病。

电泳法可用于临床研究和诊断，以改善病患照护。这种调查技术有助于识别异常蛋白质（如果存在）。它用于确定血清、血浆和尿液中不同蛋白质类别的存在。

全球电泳试剂市场概览

遗传疾病、技术进步、传染病的传播以及各国政府对基因组学和蛋白​​质组学研究的大量投入是推动全球电泳试剂市场大幅增长的关键因素。发展医疗保健基础设施、低劳动成本和增加人均收入是推动全球电泳试剂市场的其他因素。

传染病、癌症和遗传疾病的增加促使多个国家的地方政府加大研究经费投入，生物製药行业加大资金投入，以开发治疗这些疾病的有效生物药物。将会增加，预计预测期内将增加对电泳试剂的需求。

製药和生物技术产业扩大采用电泳技术，推动预测期内电泳试剂市场收入的成长。随着个人化医疗和创新药物开发的日益重视，製药公司正致力于利用基因组研究来建构直接依赖分子规模的药物，这推动了电泳试剂市场的销售成长。

对传染病、癌症和遗传问题的研究不断增加，推动了世界各地地方政府的资金投入，用于开发治疗这些疾病的有效生物药物，而这些药物供应不足。捐款。凝胶电泳测试耗时、测试程序有限以及可提高效率和结果的替代技术的可用性限制了市场的成长。

然而，缺乏技术知识和试剂产量减少可能最终导致产品召回并阻碍电泳试剂市场的发展。预测期内，人均收入水准提高和消费者医疗保健支出增加等因素也有望推动电泳试剂产业的发展。然而，电泳试剂市场的扩大可能会受到技术知识不足和试剂製造品质低落的限制，最终导致产品退货。

目录

第 1 章全球电泳试剂市场简介

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第4章 电泳试剂全球市场展望

• 概述
• 市场动态
• 驱动程式
• 阻碍因素
• 机会
• 波特五力模型
• 价值链分析

第5章 全球电泳试剂市场（依产品划分）

• 凝胶
• 染料
• 缓衝区
• 其他电泳试剂

第6章全球电泳试剂市场（依应用）

蛋白质分析 DNA 和 RNA 分析

第7章 全球电泳试剂市场（按地区）

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 德国
• 英国
• 法国
• 其他欧洲国家 亚太地区
• 中国
• 日本
• 印度
• 其他亚太地区
• 世界其他地区
• 拉丁美洲
• 中东和非洲

第 8 章全球电泳试药市场：竞争格局

• 概述
• 各公司的市场排名
• 主要发展策略

第9章 公司简介

• Thermo Fisher Scientific
• Sigma-Aldrich Corporation
• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• Merck Millipore
• GE Healthcare
• Agilent Technologies, Inc.
• Lonza Group, AG
• Takara Bio, Inc.
• Harvard Bioscience, Inc.
• Sebia Group

第 10 章附录

• 相关报告

Electrophoresis Reagents Market Size And Forecast

Electrophoresis Reagents Market size was valued at USD 1.21 Billion in 2021 and is projected to reach USD 2.53 Billion by 2030, growing at a CAGR of 6.99% from 2022 to 2030. The major factors accountable for the significant growth in the Global Electrophoresis Reagents Market are owing to the rise in genetic disorders, technological advancements, infectious diseases, and cancer, and high investments by governments in genomics and proteomics research in several regions. The other factors accountable for the Global Electrophoresis Reagents Market are improvements in healthcare infrastructure, low labor costs, and growing per capita income. The Global Electrophoresis Reagents Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Electrophoresis Reagents Market Definition

Electrophoresis is a method that is used to separate RNA, DNA, and protein based on fragments or molar mass using an electrical charge. The reagents used in the electrophoresis technique are known as electrophoresis reagents. Medical studies, clinical applications, and biosciences are all instances of industries that apply the approach. Viral infections and genetic disorders can be diagnosed using electrophoresis reagents.

It is applied in clinical research and clinical diagnostics to improve patient treatment. The methodology helps in the identification of aberrant proteins that are made up if any exist. It's used to check the presence of different protein classes in serum, plasma, as well as urine.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Electrophoresis Reagents Market Overview

The expansion in genetic disorders, technological advancements, and contagious diseases, as well as significant government expenditure in genomics and proteomics research in a variety of countries, are the important components contributing to the significant growth in the Global Electrophoresis Reagents Market. Developments in healthcare infrastructure, low labor costs, and rising per capita revenue are among the other factors driving for worldwide Electrophoresis Reagents Market.

Growing rates of contagious diseases, cancer, and genetic problems are anticipated to enhance funding for research from local authorities in several countries, and also private money from biopharmaceutical companies, for the creation of efficient biologics for trying to treat these diseases, which is anticipated to enhance the requirement for electrophoresis reagents over the forecast.

Over the projected time frame, the rising adoption of electrophoresis techniques in the pharmaceutical and biotechnology businesses is responsible for driving sales increases in the Electrophoresis Reagents Market. With the increasing emphasis on personalized medicine and innovative pharmaceutical development, pharmaceutical companies are focusing on building pharmaceuticals that directly depend on the molecular scale utilizing genomic investigations, which is expected to drive revenue growth in the Electrophoresis Reagents Marketplace.

Rising interest rates for infectious diseases, cancer, and genetic problems are projected to increase funding for research from local governments worldwide, as well as private donations from pharmaceutical companies, for the development of effective biologic drugs to cure these diseases, which is missing. Time-consuming techniques and limiting testing procedures via gel electrophoresis, and also the availability of substitute techniques that provide improved efficiencies and results, are restricting the market's growth.

However, a lack of technical knowledge and reduced reagent production, which finally leads to product recalls, may impede the Electrophoresis Reagents Market development. Over the projection timeframe, factors including increasing per-income levels and increased customer healthcare expenditure are also expected to boost the electrophoresis reagents industry. However, the Electrophoresis Reagents Market's expansion may be limited by inadequate technical knowledge and the manufacturing of low-quality reagents, which eventually lead to product returns.

Global Electrophoresis Reagents Market: Segmentation Analysis

The Global Electrophoresis Reagents Market is Segmented on the basis of Product, Application, And Geography.

Electrophoresis Reagents Market, By Product

• Gels
• Dyes
• Buffers
• Other Electrophoresis Reagents

Based on Product, the market is segmented into Gels, Dyes, Buffers, and Other Electrophoresis Reagents. Due to the increasing use of gels in protein determination and DNA & RNA analysis, the gel segment accounted for the largest share of the Global Electrophoresis Reagents Market in 2021.

Electrophoresis Reagents Market, By Application

• Protein Analysis
• DNA & RNA Analysis

Based on Application, the market is segmented into Protein Analysis and DNA & RNA Analysis. This market has been dominated by the protein analysis sector in the year 2021. This is mainly attributed to the rising focus of pharmaceutical and biotechnology on the proteomic study.

Electrophoresis Reagents Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Regional Analysis, the Global Electrophoresis Reagents Market is segmented into North America, Europe, Asia Pacific, and the Rest of the world. North America held the largest market share in 2021 and is expected to continue its dominance over the forecast period. The growth of the market for electrophoresis reagents in the North American segment can be attributed to a rising number of proteomic and genotyping research studies in Canada and the United States. In addition, increasingly stringent regulatory prerequisites for the pharma industry across the region further drive the growth of the market.

Key Players

• The "Global Electrophoresis Reagents Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Thermo Fisher Scientific, Sigma-Aldrich Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Merck Millipore, GE Healthcare, Agilent Technologies, Inc., Lonza Group, AG, Takara Bio, Inc., Harvard Bioscience, Inc., Sebia Group.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• Merck Millipore (US) finalized its acquisition of Sigma-Aldrich in 2015. (U.S.)
• Agilent Technologies Inc. (USA) purchased Seahorse Bioscience in 2015. (U.S.).
• The IH-500, a completely automated random access system for blood type and screening, was introduced by Bio-Rad Laboratories, Inc. (US) in 2015.
• Agilent Technologies Inc. (US) released new SurePrint gene expression microarrays for messenger RNA profiling applications in human, mouse, and rat models in 2015.
• Thermo Fisher Scientific (US) launched a new GMP Clinical Services Facility in Singapore in 2015. The company's supply capabilities in the Asia-Pacific market were bolstered by this new plant.

TABLE OF CONTENTS

1. Introduction of Global Electrophoresis Reagents Market

• Overview of the Market
• Scope of Report
• Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

• Data Mining
• Validation
• Primary Interviews
• List of Data Sources

4. Global Electrophoresis Reagents Market Outlook

• Overview
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porters Five Force Model
• Value Chain Analysis

5. Global Electrophoresis Reagents Market, By Product

• Gels
• Dyes
• Buffers
• Other Electrophoresis Reagents

6. Global Electrophoresis Reagents Market, By Application

• Protein Analysis
• DNA & RNA Analysis

7. Global Electrophoresis Reagents Market, By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• Middle East & Africa

8. Global Electrophoresis Reagents Market Competitive Landscape

• Overview
• Company Market Ranking
• Key Development Strategies

9. Company Profiles

• Thermo Fisher Scientific
• Sigma-Aldrich Corporation
• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• Merck Millipore
• GE Healthcare
• Agilent Technologies, Inc.
• Lonza Group, AG
• Takara Bio, Inc.
• Harvard Bioscience, Inc.
• Sebia Group

10. Appendix

• Related Reports